Literature DB >> 11813207

Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancers.

Satoru Takahashi1, Shugo Suzuki, Shingo Inaguma, Yoshihisa Ikeda, Young-Man Cho, Naoki Nishiyama, Tamio Fujita, Takahiro Inoue, Takuichi Hioki, Yoshiki Sugimura, Toshikazu Ushijima, Tomoyuki Shirai.   

Abstract

BACKGROUND: In our previous study, the gene encoding the human X-box binding protein 1 (hXBP-1) was isolated as a down-regulated gene in advanced prostate cancers using cDNA-representational difference analysis (RDA). In the present investigation, we characterized alterations of hXBP-1 in prostate cancer specimens.
METHODS: Expression patterns of hXBP-1 in a series of human prostate cancers were examined by Northern blotting, mRNA in situ hybridization or immunohistochemistry. Loss of heterozygosity (LOH) analysis using microsatellite markers and gene mutation analysis in the hXBP-1 region were also performed.
RESULTS: Expression of hXBP-1 was localized in epithelial and adenocarcinoma cells of the prostate. An inverse correlation between hXBP-1 expression and histological differentiation was found in a series of prostate cancers without hormonal therapy. Majority of refractory cancer cases exhibited weak hXBP-1 expression. No allelic loss or gene mutations were found in the hXBP-1 region and its open reading frame, respectively, in the prostate cancer examined.
CONCLUSIONS: These results suggest that reduction of hXBP-1 expression may be a useful marker for prostate adenocarcinoma differentiation and progression. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813207     DOI: 10.1002/pros.10044

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  7 in total

Review 1.  The unfolded protein response and cancer: a brighter future unfolding?

Authors:  Peter Scriven; Nicola J Brown; A Graham Pockley; Lynda Wyld
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

2.  Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach.

Authors:  Brian T Kawasaki; Elaine M Hurt; Madhuri Kalathur; Maria Ana Duhagon; John A Milner; Young S Kim; William L Farrar
Journal:  Prostate       Date:  2009-06-01       Impact factor: 4.104

3.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

4.  Expression of inositol-requiring enzyme 1β is downregulated in colorectal cancer.

Authors:  Yalin Jiang; Yunfeng Zhou; Yufeng Zheng; Hong Guo; Lei Gao; Pan Chen; Dandan Feng; Ran Qi; Xiaozhen Li; Yongchao Chang; Fong-Fong Chu; Qiang Gao
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

Review 5.  Prostate cancer and the unfolded protein response.

Authors:  Margrethe Storm; Xia Sheng; Yke Jildouw Arnoldussen; Fahri Saatcioglu
Journal:  Oncotarget       Date:  2016-08-16

6.  Effects of intrapulmonary viral tropism and cytokine expression on the histological patterns of cytomegalovirus pneumonia.

Authors:  Yoshifumi Arai; Takashi Tsuchida; Isao Kosugi; Hideya Kawasaki; Shiori Meguro; Mana Kinoshita; Satoshi Baba; Matsuyoshi Maeda; Yuichiro Shinmura; Yoshihiro Tsutsui; Toshihide Iwashita
Journal:  Pathol Int       Date:  2012-09       Impact factor: 2.534

7.  Androgen receptor profiling predicts prostate cancer outcome.

Authors:  Suzan Stelloo; Ekaterina Nevedomskaya; Henk G van der Poel; Jeroen de Jong; Geert J L H van Leenders; Guido Jenster; Lodewyk F A Wessels; Andries M Bergman; Wilbert Zwart
Journal:  EMBO Mol Med       Date:  2015-11       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.